-
Here's where you can find us!
-
IRB reviews a wide variety of research involving human subjects.
-
FDA regulations require IRB review for all drug and device studies.
IRB UPDATES
To view the latest updates from the IRB, visit our Updates Page
Consent regarding Human Biological Materials
August 26, 2022
Investigators are reminded that obtaining blood samples or other biological specimens for research, whether from a patient or from an employee or other normal volunteer, for use now or in the future, requires IRB approval and written informed consent. This includes drawing blood as “controls” for in vitro assays, unless those assays are performed solely for clinical purposes (and usually in a CLIA certified laboratory).
The IRB is happy to work with you to develop protocols to encompass a number of different activities involving collection of samples from human subjects, and to discuss further. Please contact us.
Conducting human subject research without IRB approval and informed consent, including obtaining blood or other biospecimens for any research purpose, is serious non-compliance and may be reported to HHS, FDA, NIH, or other Federal authorities."
____________________________________________________________________________
cIRB Application Update
June 24, 2022
1. The CIRB application has been updated to include a contact information sheet which can be automatically generated in RSS. This contact sheet includes the Rights of Research Subjects and Research Questions.

b. When all personnel have been selected, click “Save” and the page will refresh.
c. Select “Contact Information Sheet” from the left side menu to generate a pdf that includes a list of authorized personnel and the last 2 pages appended to any consent form.

2. Additional questions have been added to the CIRB application:
b. “Will subjects age 18 years of age or younger be included in this research?” If yes, prompted to enter age range.
c. “Method of Subject Identification and Recruitment” section added for consistency with other IRB applications and to ensure UNMC investigators are following UNMC policies.
d. “Process of Informed Consent” section added for consistency with other IRB application and to ensure UNMC investigators are following UNMC policies.
____________________________________________________________________________
Financial Interest Disclosure
June 21, 2022
As of June 21, 2022, PIs and Faculty Advisors must personally complete the Financial Interest Disclosure questions at the time they are signing section I of the application. Though other research personnel may collaborate on completing other sections of the IRB application, no one other than the individuals signing the application will have the ability to answer the financial disclosure questions. This change applies not only to new applications but also to approved applications when a change request is initiated.
____________________________________________________________________________
Revised Paper Continuing Review Forms
June 17, 2022
The continuing review applications for existing paper applications have been revised. These forms have been revised to remove personnel changes from the continuing review so that the continuing review and personnel changes on paper applications are handled like the electronic applications in RSS. These forms can be found on the IRB website: https://www.unmc.edu/irb/procedures/forms/paper-protocols.html